A significant advance in cancer investigation is arising with the use of VHH fragments to restore dysfunctional p53. This essential malignant inhibitor protein is frequently disabled in many types of tumors, leading https://mediajx.com/story304874/mini-antibodies-restore-the-p53-protein-new-promising-approach-for-tumor-treatment